Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide adjunct to insulin in type 1 diabetes
2012-005778-74Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in diabetes mellitus type 1 (T1D), sponsored by Novo Nordisk. Started Jan 2014; status: completed.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2012-005778-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005778-74.